Compass Capital Management Inc. Raises Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

Compass Capital Management Inc. increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 141,757 shares of the medical research company’s stock after acquiring an additional 3,264 shares during the quarter. Thermo Fisher Scientific makes up about 4.1% of Compass Capital Management Inc.’s portfolio, making the stock its 11th biggest holding. Compass Capital Management Inc.’s holdings in Thermo Fisher Scientific were worth $26,917,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Bank of Nova Scotia Trust Co. purchased a new stake in shares of Thermo Fisher Scientific during the third quarter worth $106,000. Ropes Wealth Advisors LLC grew its holdings in shares of Thermo Fisher Scientific by 15.8% during the second quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock worth $124,000 after buying an additional 97 shares in the last quarter. Atlantic Trust LLC purchased a new stake in shares of Thermo Fisher Scientific during the second quarter worth $138,000. Acrospire Investment Management LLC grew its holdings in shares of Thermo Fisher Scientific by 66.7% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the medical research company’s stock worth $174,000 after buying an additional 400 shares in the last quarter. Finally, Glassman Wealth Services grew its holdings in shares of Thermo Fisher Scientific by 23.1% during the second quarter. Glassman Wealth Services now owns 1,039 shares of the medical research company’s stock worth $181,000 after buying an additional 195 shares in the last quarter. 86.11% of the stock is owned by institutional investors.

TMO has been the subject of a number of research reports. ValuEngine raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Deutsche Bank set a $226.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. Morgan Stanley upped their target price on shares of Thermo Fisher Scientific from $223.00 to $227.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. BTIG Research initiated coverage on shares of Thermo Fisher Scientific in a report on Friday, January 5th. They set a “buy” rating and a $230.00 target price for the company. Finally, Evercore ISI began coverage on shares of Thermo Fisher Scientific in a report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 target price for the company. Two analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Thermo Fisher Scientific presently has a consensus rating of “Buy” and a consensus target price of $220.50.

In other Thermo Fisher Scientific news, insider Patrick M. Durbin sold 6,000 shares of the company’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $217.55, for a total value of $1,305,300.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Gregory J. Herrema sold 33,327 shares of the company’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $219.70, for a total transaction of $7,321,941.90. Following the completion of the transaction, the senior vice president now directly owns 60,471 shares in the company, valued at approximately $13,285,478.70. The disclosure for this sale can be found here. Insiders sold 94,327 shares of company stock worth $19,260,542 in the last ninety days. 0.49% of the stock is currently owned by corporate insiders.

Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $208.31 on Thursday. Thermo Fisher Scientific Inc. has a 1 year low of $151.74 and a 1 year high of $226.44. The company has a current ratio of 1.35, a quick ratio of 0.92 and a debt-to-equity ratio of 0.74. The firm has a market cap of $81,602.56, a PE ratio of 37.20, a PEG ratio of 1.49 and a beta of 1.11.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, January 31st. The medical research company reported $2.79 EPS for the quarter, beating the Zacks’ consensus estimate of $2.66 by $0.13. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.72 billion. During the same quarter in the prior year, the company posted $2.41 earnings per share. Thermo Fisher Scientific’s revenue for the quarter was up 22.1% compared to the same quarter last year. analysts expect that Thermo Fisher Scientific Inc. will post 10.81 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be given a $0.17 dividend. The ex-dividend date of this dividend is Wednesday, March 14th. This represents a $0.68 dividend on an annualized basis and a yield of 0.33%. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. Thermo Fisher Scientific’s dividend payout ratio is presently 10.71%.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Week Herald and is owned by of Week Herald. If you are accessing this report on another publication, it was illegally copied and republished in violation of U.S. & international copyright law. The original version of this report can be read at https://weekherald.com/2018/02/15/compass-capital-management-inc-acquires-3264-shares-of-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply